EUVIMEDEUVIMED entdecken
Crossref

A STUDY ON TOTAL LYMPHOCYTE COUNT AND CD4 COUNT IN HIV AFFECTED PATIENTS

Dennis Amboja

International Journal of Biological Studies · 2022

DOI: 10.47941/ijbs.900 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Studies, 2022. Verfasst von Dennis Amboja.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

The study aimed to assess the total lymphocyte count and CD4 count in HIV affected patients. Methodology: The approach we used in this study was to gather and analyze a wide range of research articles.

Findings

Worldwide estimates of people living with Human Immunodeficiency Virus was approximately 32 million in 2007 with thousands of people getting infected every day. Most people living with HIV are from developing countries with less than 5% receiving antiretroviral therapy. In 2009, an estimated 2.6 million people became infected out of which approximately 1.8 million were from sub-Saharan Africa. The initiation of antiretroviral therapy is based on CD4 counts of less than 350 cells/mm3 according to the World Health Organization (WHO) and Centre for Disease Control (CDC). The determination of CD4 count however in resource-limited localities is difficult. A total lymphocyte count (TLC) of

Zitieren

APA

Amboja, D. (2022). A STUDY ON TOTAL LYMPHOCYTE COUNT AND CD4 COUNT IN HIV AFFECTED PATIENTS. International Journal of Biological Studies. https://doi.org/10.47941/ijbs.900

Vancouver

Amboja D. A STUDY ON TOTAL LYMPHOCYTE COUNT AND CD4 COUNT IN HIV AFFECTED PATIENTS. International Journal of Biological Studies. 2022. doi:10.47941/ijbs.900

BibTeX
@article{Amboja2022,
  author = {Amboja, Dennis},
  title = {A STUDY ON TOTAL LYMPHOCYTE COUNT AND CD4 COUNT IN HIV AFFECTED PATIENTS},
  journal = {International Journal of Biological Studies},
  year = {2022},
  doi = {10.47941/ijbs.900}
}
Kostenlos starten →